Andrew D Cherniack

32PUBLICATIONS
302CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Cancer geneticsHealth and ecological risk assessmentPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Oct 15, 2025
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer.

Franziska Siegel, Stephan Siegel, Kristýna Kotýnková

|May 16, 2025
Clinicogenomic Characterization of Inflammatory Breast Cancer.

Nolan Priedigkeit, Beth Harrison, Robert Shue

|May 12, 2025
Three-dimensional genome landscape of primary human cancers.

Kathryn E Yost, Yanding Zhao, King L Hung

|Sep 30, 2024
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.

Brandon M Huffman, Osama E Rahma, Kevin Tyan

|Sep 05, 2024
Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers.

Laksshman Sundaram, Arvind Kumar, Matthew Zatzman

|Aug 22, 2024
Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.

Suzanne J Forrest, Hersh Gupta, Abigail Ward

Pageof 6

Frequent Collaborators

13 joint publications

Matthew Meyerson

9 joint publications

Yvonne Y Li

4 joint publications

Galen Gao

4 joint publications

Aviad Tsherniak